Source comparison
MOTS-c vs SS-LUP-332: Research Applications Comparison
Researchers frequently encounter decision points where peptide selection determines experimental feasibility. The table below maps each compound's strengths to specific research questions. Insulin Resistance Models Activates AMPK independent of insulin signali
This comparison does not assign a generated winner or score.
- Researchers frequently encounter decision points where peptide selection determines experimental feasibility. The table below maps each compound's strengths to specific research questions.
- Insulin Resistance Models
- Activates AMPK independent of insulin signaling; restores glucose tolerance without affecting insulin secretion
- Minimal direct effect on insulin sensitivity; improvements secondary to reduced adiposity
- MOTS-c is the primary choice for insulin resistance studies. Mechanism directly addresses impaired glucose uptake
- Age-Related Metabolic Decline
- Demonstrated efficacy in aged mice; addresses mitochondrial dysfunction underlying metabolic aging
- Limited data in aging models; mechanism targets fat distribution rather than mitochondrial capacity
- MOTS-c addresses root cause of age-related metabolic decline; SS-LUP-332 addresses downstream adipose changes
- Sex-Specific Metabolic Research
- No sex-specific mechanism; effects consistent across male and female models
- ERβ selectivity makes it ideal for studying estrogen-mediated metabolic differences
- SS-LUP-332 is purpose-built for examining estrogen's role in metabolic regulation without reproductive tissue effects
- Visceral Adiposity Studies
- Reduces visceral fat through enhanced oxidation, but not tissue-selective
- Selectively reduces visceral adipose without affecting subcutaneous depots. Reflects ERβ distribution
- SS-LUP-332 offers tissue-specific fat reduction that MOTS-c cannot achieve
- Mitochondrial Biogenesis
- Directly upregulates PGC-1α and increases mitochondrial content 20–25% within 14 days
- No direct mitochondrial biogenesis pathway; may indirectly increase mitochondrial density through UCP1 activation
- MOTS-c is the only option for studying mitochondrial biogenesis signaling pathways
- Thermogenesis and Energy Expenditure
- Increases basal metabolic rate through mitochondrial efficiency gains; modest thermogenic effect
- Upregulates UCP1 in brown adipose tissue; increases thermogenesis 15–20% in rodent models
- Both increase energy expenditure through different mechanisms. Choice depends on whether brown adipose activation is the research focus
- Vascular Function Studies
- No direct vascular effects; metabolic improvements may indirectly benefit endothelial function
- Activates eNOS through ERβ; improves vascular reactivity independent of metabolic changes
- SS-LUP-332 is the better choice for studies examining metabolic-vascular interactions